Statement of Cash Flows (Tables)

12 Months Ended

Dec. 31, 2024

Cash and Cash Equivalents [Abstract]

Schedule of cash and cash equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets to the total of the same such amounts shown in the Consolidated Statements of Cash Flows:

	December 31,
(In millions)	2024		2023		2022
Cash and cash equivalents	$	2,488.2	$	2,730.0	$	3,105.9
Restricted cash included in Other current assets	0.8		—		—
Restricted cash included in Other noncurrent assets	—		7.8		13.5
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$	2,489.0	$	2,737.8	$	3,119.4

Schedule of restrictions on cash and cash equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets to the total of the same such amounts shown in the Consolidated Statements of Cash Flows:

	December 31,
(In millions)	2024		2023		2022
Cash and cash equivalents	$	2,488.2	$	2,730.0	$	3,105.9
Restricted cash included in Other current assets	0.8		—		—
Restricted cash included in Other noncurrent assets	—		7.8		13.5
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$	2,489.0	$	2,737.8	$	3,119.4

Summary of non-cash investing and financing activities

Supplemental disclosure of non-cash investing and financing activities

	As of December 31,
(In millions)	2024		2023		2022
Accrued capital expenditures	$	151.6	$	75.4	$	70.8
Accrued contingent consideration in connection with acquisitions	$	62.7	$	71.6	$	135.5